Niraparib Tosylate is a potent poly (ADP-ribose) polymerase (PARP) inhibitor used in targeted oncology therapy to disrupt DNA repair mechanisms in cancer cells, specifically indicated for the treatment… Read more
Niraparib Tosylate is a potent poly (ADP-ribose) polymerase (PARP) inhibitor used in targeted oncology therapy to disrupt DNA repair mechanisms in cancer cells, specifically indicated for the treatment of certain solid tumors such as ovarian cancer. This category provides access to high-quality reference standards for the Niraparib Tosylate active pharmaceutical ingredient (API), which are essential for pharmaceutical laboratories conducting rigorous analytical testing and method validation. Included in this collection are pharmacopeial and non-pharmacopeial impurities, critical metabolites, and stable isotope-labelled compounds required for accurate impurity profiling and precise quantification during drug development. By utilizing these characterized reference materials, researchers can ensure compliance with regulatory standards for quality control and support the development of reliable analytical procedures for assessing stability and purity in clinical and laboratory environments.